Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Presenter
Browse by Presenter
Browse by Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
H
Hallet, Julie
University of Toronto
Resection of <1-2cm Nonfunctional Pnets
Julie Hallet
Hanna, Andrew
University of Pennsylvania
78: Is Gastrointestinal Stromal Tumor Progression Mediated by Class I Downregulation?
Andrew Hanna
78: Q&A
Andrew Hanna
V74: Clinicopathologic Factors Predictive of Recurrence in Lymph Node-negative Gastric Adenocarcinoma
Andrew Hanna
Hanna, David
Vanderbilt University Medical Center
A30: Impact of Different Systemic Chemotherapy Approaches on Oncologic Outcomes for Patients with Colorectal Peritoneal Metastases
David Hanna
A30: Q&A
David Hanna
A41: Q&A
David Hanna
A41: Total Neoadjuvant systemic Chemotherapy Is Associated with Improved Oncologic Outcomes in Patients with Appendiceal Adenocarcinoma Peritoneal Metastases
David Hanna
Hanna, Nader
University of Maryland School of Medicine
Multivisceral Resection for Colon Cancer
Nader Hanna
Hao, Scarlett
Brody School of Medicine at East Carolina University
V73: Leveraging the Electronic Health Record to Measure Social Determinants of Health in Patients with Gastrointestinal Cancer: A Feasibility Study
Scarlett Hao
Harper, Megan
University of Kentucky
A48: Pharmacokinetics of Nano-liposomal Irinotecan in a Phase 1 Study for Patients with Peritoneal Disease Treated with Heated Intraperitoneal Chemotherapy
Megan Harper
A48: Q&A
Megan Harper
Hayes, Andrew
Royal Marsden Hospital
Panel Discussion & Case Presentation
Andrew Hayes
Hendrick, Leah
UTHSC Department of Surgery
22: Patterns of Differential Gene Expression May Provide Potential Biomarkers for Anal Cancer Progression
Leah Hendrick
22: Q&A
Leah Hendrick
Hernandez, Jonathan
National Institutes of Health
Precision Medicine for the Surgical Oncologist: Current and Future Strategies
Jonathan Hernandez
Q&A and Discussion
Jonathan Hernandez
Herremans, Kelly
University of Florida
V44: Location, Location, Location- clinical Trial Location Does Not Influence the Diversity of Pancreatic Cancer Clinical Trials
Kelly Herremans
Hewitt, Daniel
The Ohio State University Medical Center - Columbus, OH
67: Bilateral Robotic-assisted Nipple-sparing Mastectomy Using a Single Incision
Daniel Hewitt
67: Q&A
Daniel Hewitt
Hieken, Tina
Mayo Clinic
9: Inflammatory Breast Cancer: durable Breast Cancer-specific Survival for HER2+ Patients with a Pathologic Complete Response to Neoadjuvant Therapy
Tina Hieken
9: Q&A
Tina Hieken
Neoadjuvant Therapy in Melanoma
Tina Hieken
Hines, O. Joe
David Geffen School of Medicine at UCLA
The Certifier of the Surgeon Perspective
O. Joe Hines
Hirpara, Dhruvin
University of Toronto
V61: Association Between Patient-reported Symptoms and Healthcare Resource Utilization: A First Step to Develop Patient-centered Value Measures in Cancer Care
Dhruvin Hirpara
Hitscherich, Kyle
National Institutes of Health
V81 Validation of GIST Nomogram Performance from a Statewide Community Cancer Center
Kyle Hitscherich
Hochwald, Steven
Roswell Park Comprehensive Cancer Center
Pro Total Gastrectomy
Steven Hochwald
Hogg, Melissa
NorthShore
Discussions and Q&A
Melissa Hogg
Integration of Molecular Analysis in the Multidisciplinary Management of HPB Neoplasms
Melissa Hogg
Panel: Pursuing a Career in Academia versus Private Practice
Melissa Hogg
SSO 2022 Pre-meeting Robotics Surgery
Melissa Hogg
Holder, Ashley
University of Alabama at Birmingham
ACT Melanoma Abstract Presentations
Ashley Holder
Melanoma, Quality and Disparities Virtual Poster Grand Rounds
Ashley Holder
Hong, Young
Cooper University Hospital
Efficacy and Feasibility of Adoptive Cellular Therapy for Metastatic Melanoma: Are We Ready for Commercialization?
Young Hong
Hoover, Susan
Moffitt Cancer Center
Exploring Innovative Surgeon-driven Technology for Intraoperative Specimen Evaluation
Susan Hoover
Hoshi, Hisakazu
University of Iowa Hospitals and Clinics
Panel Discussion & Case Presentation
Hisakazu Hoshi
Whoops! Now What? The Unexpected Positive Margin in Sarcoma Surgery
Hisakazu Hoshi
Hsieh, David
University of Texas Southwestern Medical Center
Discussions and Q&A
David Hsieh
Huis in t veld, Eva
Erasmus MC
V63: Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma
Eva Huis in t veld
HUNDEYIN, MAUTIN
MEMORIAL SLOAN KETTERING CANCER CENTER
72: Q&A
MAUTIN HUNDEYIN
72: Robotic Proximal Gastrectomy with Double Tract Reconstruction for Locally Advanced Siewert II Gastroesophageal junction Cancer
MAUTIN HUNDEYIN
Hunt, Kelly
The University of Texas MD Anderson Cancer Center
Methods for Intraoperative Detection of Positive Margins in Breast Conserving Surgery (Lumicell Industry Spotlight)
Kelly Hunt
Hwang, Rosa
The University of Texas MD Anderson Cancer Center
Robotic Mastectomy—the Skeptical Surgeon
Rosa Hwang
Hwang, Shelley
Duke University
20: Q&A
Shelley Hwang
20: The Clinical Impact of Intraoperative Margin Assessment in Breast Cancer Surgery
Using A Novel Pegulicianine Fluorescence Guided Surgery System: A Prospective Single Arm Study
Shelley Hwang
Hydrick, Thomas
Mayo Clinic Alix School of Medicine
V59: Trends in Reimbursement for Index Surgical Oncology Procedures in Contemporary Practicedeclining Reimbursement for Surgical Oncology Procedures – How Low Do We Go?
Thomas Hydrick
Hyngstrom, John
Huntsman Cancer Institute, University of Utah Health
Acral
John Hyngstrom
Presentation of cases and panel discussion
John Hyngstrom
Q&A
John Hyngstrom
Rare Subtypes Melanoma
John Hyngstrom
Back to Top
